
Douglas Elliman (NYSE:DOUG) reported a challenging Q2 2025, with revenue declining 5% year-over-year to $271.4 million and adjusted EBITDA swinging to a loss of $(0.8) million from a positive $2.9 million, reflecting significant margin pressure and weaker profitability. Gross Transaction Value also fell 3.8% to $10.2 billion amidst reduced transaction volumes. The GAAP net loss expanded sharply to $22.7 million, primarily due to a $17 million non-cash derivative revaluation charge and litigation expenses. Notably, management provided no quantitative financial guidance for the second half of fiscal 2025, leaving investors without clear forward expectations for the luxury real estate brokerage.
Douglas Elliman (NYSE:DOUG) reported a weak second quarter for fiscal 2025, characterized by deteriorating top-line and profitability metrics. Revenue declined 5% year-over-year to $271.4 million, driven by a reduction in both transaction volumes, which fell to 5,530 from 5,885, and Gross Transaction Value, which slipped 3.8% to $10.2 billion. While the average price per transaction remained robust at $1.84 million, underscoring the company's luxury market focus, it was insufficient to offset the lower deal flow. Profitability eroded significantly, with adjusted EBITDA swinging to a loss of $(0.8) million from a $2.9 million profit in the prior-year period, and adjusted net loss per share worsening to $0.06. The GAAP net loss expanded dramatically to $22.7 million, although this figure was heavily impacted by a $17.0 million non-cash loss from a change in fair value of convertible debt derivatives and $1.06 million in litigation expenses. Critically, management provided no quantitative financial guidance for the second half of the fiscal year, creating significant uncertainty around the company's near-term outlook and leaving its strong cash position of $136.3 million as the primary financial backstop against operational headwinds.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly negative
Sentiment Score
-0.75
Ticker Sentiment